TIE1

mass-spec protein & survival
Survivalmass-specKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, TIE1 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated TIE1 data layer compared with 25 for mass-spec protein and 10 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher TIE1 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated TIE1 expression acts as an unfavorable survival marker.

LUAD and LSCC are the cancer types where TIE1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
LUADOSMedianAll0.5960.868.01111view →
LSCCDFSMedianII,III,IV0.8720.970.0104view →
Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

TIE1–LUAD (OS)

Kaplan–Meier survival curve for TIE1 mass-spec protein-high vs -low samples in LUAD.

Open the LUAD breakdown →

Exploration